Kashishian A, MacAuley A, Cooper J A
Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Oncogene. 1990 Oct;5(10):1463-70.
To evaluate the possible regulatory effects of interactions between different domains of Src-family kinases, we have assembled five chimeric molecules containing parts of p60c-src (Src) and p56lck (Lck). Chimeras contained the N-terminal portion, kinase domain or C-terminal tail from either of the parent molecules. None of the four full-length hybrid proteins induced morphological transformation of NIH3T3 cells, nor stimulated phosphorylation of cell proteins on tyrosine residues, suggesting that their protein-tyrosine kinase activities were repressed appropriately in fibroblastic cells. However, two hybrid proteins, SLS and SLL, containing the Src N-terminal region, Lck kinase domain, and either Src or Lck tail, respectively, inefficiently induced anchorage-independent growth. Sites of phosphorylation in these molecules were determined by two-dimensional peptide mapping. SLS and SLL were both phosphorylated at their C-terminal tyrosine residues similarly to the parental molecules. Curiously, both proteins were also significantly phosphorylated at tyrosine 416, a feature of transforming variants of Src and Lck. A modified hybrid, SLO, containing the N-terminal region of Src, kinase domain of Lck and a truncated C-terminus, fully transformed cells and stimulated phosphorylation of cell proteins at tyrosine. Comparison of SLS, SLL and SLO suggests that the full-length hybrids are repressed by their C-terminal phosphorylated tyrosine residues in vivo. Consistent with this, SLO resembled activated Src in being cytoskeletal, and SLS and SLL resembled nontransforming Src and were not cytoskeletal. Hybrids with an Lck N-terminal region were cytoskeletal, like Lck itself, even though they were not transforming, suggesting that cytoskeletal localization of Lck is determined through its N terminus. Curiously, the hybrid molecules appeared not to be regulated in vitro. The specific activities of SLS, SLL and Src were approximately equal, but the specific activity of SLO was not increased, being much less than that of activated Src. Enzymatic dephosphorylation stimulated the in vitro kinase activity of parental Src, but not of SLS or SLL. These observations suggest that chimeric Src-Lck molecules are regulated in the cell, but not in vitro.
为了评估Src家族激酶不同结构域之间相互作用可能产生的调控效应,我们构建了五个嵌合分子,它们包含了p60c-src(Src)和p56lck(Lck)的部分结构。嵌合体包含来自任一亲本分子的N端部分、激酶结构域或C端尾巴。四个全长杂交蛋白均未诱导NIH3T3细胞发生形态转化,也未刺激细胞蛋白酪氨酸残基的磷酸化,这表明它们的蛋白酪氨酸激酶活性在成纤维细胞中受到了适当抑制。然而,两个杂交蛋白,即分别含有Src N端区域、Lck激酶结构域以及Src或Lck尾巴的SLS和SLL,低效地诱导了非贴壁依赖性生长。通过二维肽图分析确定了这些分子中的磷酸化位点。SLS和SLL在其C端酪氨酸残基处的磷酸化情况与亲本分子相似。奇怪的是,这两种蛋白在酪氨酸416处也有明显的磷酸化,这是Src和Lck转化变体的一个特征。一个经过修饰的杂交蛋白SLO,包含Src的N端区域、Lck的激酶结构域和一个截短的C端,能完全转化细胞并刺激细胞蛋白在酪氨酸处的磷酸化。对SLS、SLL和SLO的比较表明,全长杂交蛋白在体内受到其C端磷酸化酪氨酸残基的抑制。与此一致的是,SLO类似于活化的Src,定位于细胞骨架,而SLS和SLL类似于非转化型Src,不定位于细胞骨架。具有Lck N端区域的杂交蛋白,即使它们不具有转化能力,也像Lck本身一样定位于细胞骨架,这表明Lck的细胞骨架定位是通过其N端决定的。奇怪的是,这些杂交分子在体外似乎不受调控。SLS、SLL和Src的比活性大致相等,但SLO的比活性并未增加,远低于活化Src的比活性。酶促去磷酸化刺激了亲本Src的体外激酶活性,但对SLS或SLL则没有作用。这些观察结果表明,嵌合的Src-Lck分子在细胞内受到调控,但在体外不受调控。